Q4 2024 Holdings
Filed 2025-02-14 | 80 holdings | $433.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuveen Churchill Direct Lend(NCDL) | COM SHS | 67090S108 | $67.8M | 4,039,553 | 15.6% |
| Klaviyo Inc(KVYO) | COM SER A | 49845K101 | $44.5M | 1,078,770 | 10.3% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $36.5M | 2,769,199 | 8.4% |
| Blue OWL Capital Corporation(OBDC) | COM | 69121K104 | $30.9M | 2,045,070 | 7.1% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $28.9M | 2,370,972 | 6.7% |
| Conduent Inc(CNDT) | COM | 206787103 | $22.7M | 5,625,459 | 5.2% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $21.9M | 1,079,321 | 5.0% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $21.0M | 3,159,975 | 4.8% |
| Evercommerce Inc(EVCM) | COM | 29977X105 | $18.1M | 1,641,929 | 4.2% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $18.0M | 4,653,040 | 4.2% |
| Gohealth Inc(GOCO) | CL A NEW | 38046W204 | $11.1M | 83,264 | 2.6% |
| Holley Inc(HLLY) | COM | 43538H103 | $9.0M | 2,990,294 | 2.1% |
| Acelyrin Inc | COM | 00445A100 | $8.7M | 2,783,946 | 2.0% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $8.1M | 1,959,912 | 1.9% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $7.6M | 120,260 | 1.8% |
| Ikena Oncology Inc | COM | 45175G108 | $6.7M | 4,091,118 | 1.5% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $6.7M | 6,357,928 | 1.5% |
| Sagimet Biosciences Inc(SGMT) | COM SER A | 786700104 | $6.0M | 1,323,877 | 1.4% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $5.4M | 1,732,152 | 1.2% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $5.0M | 118,238 | 1.1% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $5.0M | 667,594 | 1.1% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $4.5M | 3,443,659 | 1.0% |
| E2open Parent Holdings Inc(ETWOGBP) | COM CL A | 29788T103 | $4.4M | 1,650,943 | 1.0% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $4.3M | 2,954,712 | 1.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $3.8M | 242,633 | 0.9% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $3.7M | 220,000 | 0.8% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $3.2M | 900,000 | 0.7% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $3.0M | 250,062 | 0.7% |
| Inozyme Pharma Inc | COM | 45790W108 | $3.0M | 1,080,027 | 0.7% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $2.4M | 672,809 | 0.5% |
| Marker Therapeutics Inc(MRKR) | COM NEW | 57055L206 | $1.7M | 554,250 | 0.4% |
| Aeon Biopharma Inc | CL A | 00791X100 | $1.6M | 3,049,361 | 0.4% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $1.5M | 733,568 | 0.3% |
| Enterprise Prods Partners L(EPD) | COM | 293792107 | $981.3K | 31,290 | 0.2% |
| Omega Therapeutics Inc | COMMON STOCK | 68217N105 | $787.3K | 1,055,882 | 0.2% |
| SHF Holdings Inc | CLASS A COM | 824430102 | $683.1K | 1,517,924 | 0.2% |
| Rezolve AI LTD(RZLV) | ORD SHS | G75398100 | $669.8K | 181,667 | 0.2% |
| Marblegate Acquisition Corp | COM CL A | 56608A105 | $638.2K | 91,429 | 0.1% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $609.5K | 161,238 | 0.1% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $461.4K | 39,003 | 0.1% |
| Rezolve AI LTD | *W EXP 08/15/202 | G75398118 | $446.5K | 603,429 | 0.1% |
| Gitlab Inc(GTLB) | CLASS A COM | 37637K108 | $283.9K | 5,038 | 0.1% |
| Plum Acquisition Corp III | *W EXP 03/31/202 | G63290103 | $220.0K | 1,166,665 | 0.1% |
| Southland Hldgs Inc(SLND/WS) | *W EXP 02/14/202 | 84445C118 | $206.5K | 860,302 | 0.0% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $203.2K | 1,718 | 0.0% |
| Syntec Optics Hldgs Inc(OPTX) | CL A | 87169M105 | $124.9K | 49,575 | 0.0% |
| Alpha Modus Hldgs Inc(AMODW) | *W EXP 12/13/202 | 020952115 | $95.0K | 1,187,999 | 0.0% |
| Plum Acquisition Corp III | UNIT 03/31/2028 | G63290129 | $94.6K | 15,000 | 0.0% |
| Syntec Optics Hldgs Inc(OPTXW) | *W EXP 99/99/999 | 87169M113 | $88.3K | 803,132 | 0.0% |
| Satixfy Communications LTD | ORD SHS | M82363124 | $77.7K | 50,794 | 0.0% |